Flourish Research Acquires Diablo Clinical Research

Flourish Research is proud to announce the acquisition of Diablo Clinical Research, a premier multi-therapeutic clinical research facility based in Walnut Creek, California. Established in 1995, Diablo has conducted over 1,000 phase I-IV clinical trials and medical device studies, with particular strengths in endocrinology, cardiovascular, and metabolic research.

This strategic acquisition expands Flourish Research’s geographic footprint and therapeutic capabilities, enhancing our ability to deliver high-quality data, diverse participant enrollment, and exceptional patient experiences. With Diablo’s experienced investigators and proximity to Silicon Valley, Flourish is well-positioned to drive innovation across pharmaceuticals, emerging biotechs, and medical device studies.